Results 151 to 160 of about 13,451 (203)

Prevalence and antimicrobial resistance of <i>Acinetobacter baumannii</i> isolated from endotracheal aspirates in a tertiary-care intensive care unit from South India. [PDF]

Front Microbiol
Puttegowda D, Jayaram L, Rajshekar D, Abhinandithe K S, Pulipati S, Przybyłek M, Srinivasa C, Ramu R, Shahid M.   +8 more
europepmc   +1 more source

Penetration of cefoperazone into ascites [PDF]

European Journal of Clinical Pharmacology, 1989
The pharmacokinetics of cefoperazone was studied in eleven cirrhotic patients with ascites after i.v. administration of a single dose of 15 mg.kg-1 (n = 7) or after three doses of 15 mg.kg-1 given at 12 h intervals (n = 4). The concentrations of cefoperazone in serum and ascitic fluid were determined by HPLC.
Van Gossum, André, Quenon, Marianne, Van Gossum, Marc, Herchuelz, André, Thys, Jean-Pierre   +4 more
openaire   +4 more sources

Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study [PDF]

Expert Opinion on Drug Safety, 2020
Objectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding. Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with ...
Yu Wu, Jing Tan
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Cefoperazone

Drugs, 1981
The pharmacokinetics of cefoperazone in normal subjects, and in patients with hepatic and renal dysfunction are reviewed. After intravenous administration of 2 g of cefoperazone, levels in serum ranged from 202 to 375 microgram/ml depending on the period of drug administration.
W A, Craig, A U, Gerber
openaire   +2 more sources

Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis [PDF]

Journal of Chemotherapy
This study aim to assess the clinical efficacy and safety of generic cefoperazone/sulbactam compared to the branded cefoperazone/sulbactam (Sulperazon) in treating bacterial infections through a meta-analysis.
Yong Lai
exaly   +2 more sources

Pharmacokinetics of cefoperazone in horses

Journal of Veterinary Pharmacology and Therapeutics, 1996
The pharmacokinetics and bioavailabilty of cefoperazone (CPZ) were studied following intravenous (IV) and intramuscular (IM) administration of single doses (30 mg/kg) to horses. Concentrations in serum, urine and synovial fluid samples were measured following IV administration.
A L, Soraci, O N, Mestorino, J O, Errecalde   +2 more
openaire   +2 more sources

Cefoperazone-Induced Coagulopathy

Drug Intelligence & Clinical Pharmacy, 1986
A number of recent articles have reviewed the problem of hypoprothrombinemia and bleeding associated with antibiotic therapy. We report three cases in which bleeding is believed to be related to a prolonged prothrombin time secondary to cefoperazone therapy. Reports of coagulopathies such as these are increasing in number and call attention to the need
H R, Freedy, A B, Cetnarowski, R M, Lumish, F J, Schafer   +3 more
openaire   +2 more sources

Cefoperazone (Cefobid, Pfizer)

Drug Intelligence & Clinical Pharmacy, 1983
Cefoperazone is a new β-lactam antibiotic that possesses a broad spectrum of activity against gram-positive and gram-negative organisms. Cefoperazone differs from all previous cephalosporins in that it has exceptional activity against P. aeruginosa. The other distinguishing feature of cefoperazone is its high rate of biliary excretion, which will allow
Eric A. Jackson, Alex A. Cardoni, James A. Lyon   +2 more
openaire   +2 more sources

Cefoperazone and Prothrombin Time

Annals of Internal Medicine, 1987
Excerpt To the editor: In their article on the relationship between beta-lactam antibiotics and coagulopathy, Sattler and colleagues (1) cited our results (2) from a multicenter trial of cefoperazo...
M S, Cohen, H E, Washton
openaire   +2 more sources